
zzso pain resulting from inflammatory and zzso disorders causes considerable economic and social zzso For a substantial proportion of patients, conventional drug treatments do not provide adequate pain zzso zzso novel approaches to pain management, involving alternative targets and new therapeutic zzso compatible with chronic use, are being zzso Nerve growth factor zzso is a major zzso of chronic zzso Clinical testing of zzso zzso is zzso and clinical proof of concept has been established with a zzso zzso Active zzso with the goal of inducing zzso effective zzso zzso zzso is recognized as a potential treatment option for chronic zzso We have sought to determine if such a strategy could be applied to chronic pain by targeting zzso with a zzso particle zzso zzso A vaccine zzso zzso zzso zzso zzso to zzso from the zzso zzso zzso was zzso zzso of mice with zzso induced zzso zzso zzso capable of zzso zzso zzso could be sustained over 1 y by periodic zzso but declined in the absence of zzso zzso with zzso substantially reduced zzso in zzso arthritis or zzso of zzso A, two models of inflammatory zzso zzso zzso zzso did not change sensory or sympathetic zzso patterns or induce zzso deficits in the zzso nor did it interfere with zzso barrier zzso Thus, zzso targeting zzso using a zzso approach may represent a novel zzso for the treatment of chronic zzso 

